Corneal Thinning During Topical Bevacizumab Therapy
Not Applicable
Withdrawn
- Conditions
- Corneal Neovascularization
- Registration Number
- NCT00515684
- Lead Sponsor
- Yonsei University
- Brief Summary
The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- clinical diagnosis of corneal neovascularization
- must be able to apply eyedrop
Exclusion Criteria
- have active keratitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Severance hospital
🇰🇷Seoul, Korea, Republic of